Clinical Laboratory


Epic Sciences mission is to improve patient lives by enabling precision medicine and personalize treatments.

To accomplish our mission, we are using our proprietary circulating tumor cell (CTC) detection platform to develop predictive tests of therapy benefit.  These tests will provide essential information to physicians, helping them guide treatment decisions to extend patient lives. These tests are being developed in our Clinical Laboratory (CLIA ID: 05D2087488).

Clinical Laboratory Tests


Epic AR-V7 Test 

Characterization of nuclear AR-V7+ CTCs as a biomarker for informed mCRPC treatment decisions

learn more at




Genomic Health and Epic Sciences Announce Strategic Collaboration to Deliver Novel AR-V7 Liquid Biopsy Test

to Predict Treatment Response in Metastatic Prostate Cancer

read the press release